Does IRBESARTAN Cause Product substitution issue? 118 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 118 reports of Product substitution issue have been filed in association with IRBESARTAN (Irbesartan). This represents 1.2% of all adverse event reports for IRBESARTAN.
118
Reports of Product substitution issue with IRBESARTAN
1.2%
of all IRBESARTAN reports
0
Deaths
10
Hospitalizations
How Dangerous Is Product substitution issue From IRBESARTAN?
Of the 118 reports, 10 (8.5%) required hospitalization, and 5 (4.2%) were considered life-threatening.
Is Product substitution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 118 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Product substitution issue?
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832)
BUPROPION (1,578)
METHYLPHENIDATE (1,408)
CLONAZEPAM (1,288)
LAMOTRIGINE (979)
ALBUTEROL (864)
LEVOTHYROXINE (803)
DULOXETINE (766)
ESTRADIOL (692)
SERTRALINE (636)
Which IRBESARTAN Alternatives Have Lower Product substitution issue Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE